These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29501526)

  • 1. Corrigendum to "Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity" [Toxicol. Appl. Pharmacol. 321 (2017) 1-17].
    Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
    Toxicol Appl Pharmacol; 2018 Apr; 344():74. PubMed ID: 29501526
    [No Abstract]   [Full Text] [Related]  

  • 2. Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.
    Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
    Toxicol Appl Pharmacol; 2017 Apr; 321():1-17. PubMed ID: 28213091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice" [Toxicol. Appl. Pharmacol. 316 (2017) 74-82].
    Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
    Toxicol Appl Pharmacol; 2017 Apr; 320():73. PubMed ID: 28189653
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'Characterization of heme oxygenase and biliverdin reductase gene expression in zebrafish (Danio rerio): Basal expression and response to pro-oxidant exposures' [Toxicol. Appl. Pharmacol. 311 (2016) 74-87].
    Holowiecki A; O'Shields B; Jenny MJ
    Toxicol Appl Pharmacol; 2018 Oct; 356():98. PubMed ID: 30031761
    [No Abstract]   [Full Text] [Related]  

  • 5. Integration of the nuclear receptor REV-ERBα linked with circadian oscillators in the expressions of Alas1, Ppargc1a, and Il6 genes in rat granulosa cells.
    Chen H; Isayama K; Kumazawa M; Zhao L; Yamauchi N; Shigeyoshi Y; Hashimoto S; Hattori MA
    Chronobiol Int; 2015; 32(6):739-49. PubMed ID: 26102301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα.
    Grant D; Yin L; Collins JL; Parks DJ; Orband-Miller LA; Wisely GB; Joshi S; Lazar MA; Willson TM; Zuercher WJ
    ACS Chem Biol; 2010 Oct; 5(10):925-32. PubMed ID: 20677822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and Transient receptor potential ankyrin-1 (TRPA1)" [Toxicol Appl Pharmacol. 398 (2020) 115012].
    Jin L; Jagatheesan G; Lynch J; Guo L; Conklin DJ
    Toxicol Appl Pharmacol; 2020 Aug; 401():115114. PubMed ID: 32598891
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
    Ganapathy S; Li P; Fagman J; Yu T; Lafontant J; Zhang G; Chen C
    Toxicol Appl Pharmacol; 2017 Jan; 314():118. PubMed ID: 27851896
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Rev-erbα domains for transactivation of the connexin43 promoter with Sp1.
    Negoro H; Okinami T; Kanematsu A; Imamura M; Tabata Y; Ogawa O
    FEBS Lett; 2013 Jan; 587(1):98-103. PubMed ID: 23201262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity Toxicol Appl Pharmacol, 354 (2018) 64-80.
    Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M
    Toxicol Appl Pharmacol; 2019 Jun; 372():70. PubMed ID: 31002859
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Use of a combined effect model approach for discriminating between ABCB1- and ABCC1-type efflux activities in native bivalve gill tissue" [Toxicol. Appl. Pharmacol. (2016) 56-67].
    Faria M; Pavlichenko V; Burkhardt-Medicke K; Soares AMVM; Altenburger R; Barata C; Luckenbach T
    Toxicol Appl Pharmacol; 2016 Jul; 303():110. PubMed ID: 27157384
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Differential effects of the persistent DDT metabolite methylsulfonyl-DDE in nonstimulated and LH-stimulated neonatal porcine Leydig cells" [Toxicol. Appl. Pharmacol. 267 (2013) 247-255].
    Castellanos CG; Sørvik IB; Tanum MB; Verhaegen S; Brandt I; Ropstad E
    Toxicol Appl Pharmacol; 2017 Oct; 332():159-160. PubMed ID: 28522354
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis' [Toxicol. Appl. Pharmacol., 322 (2017) 15-26].
    Dimopoulou M; Verhoef A; Pennings J; van Ravenzwaay B; Rietjens IMCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 355():287. PubMed ID: 29980297
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective.
    Swanson HI
    Chem Biol Interact; 2004 Oct; 149(2-3):69-79. PubMed ID: 15501429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32].
    Poulsen SS; Saber AT; Williams A; Andersen O; Købler C; Atluri R; Pozzebon ME; Mucelli SP; Simion M; Rickerby D; Mortensen A; Jackson P; Kyjovska ZO; Mølhave K; Jacobsen NR; Jensen KA; Yauk CL; Wallin H; Halappanavar S; Vogel U
    Toxicol Appl Pharmacol; 2018 Sep; 355():286. PubMed ID: 29908758
    [No Abstract]   [Full Text] [Related]  

  • 16. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways.
    Yin L; Wu N; Curtin JC; Qatanani M; Szwergold NR; Reid RA; Waitt GM; Parks DJ; Pearce KH; Wisely GB; Lazar MA
    Science; 2007 Dec; 318(5857):1786-9. PubMed ID: 18006707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REV-ERB
    Zhang T; Zhao M; Lu D; Wang S; Yu F; Guo L; Wen S; Wu B
    Drug Metab Dispos; 2018 Mar; 46(3):248-258. PubMed ID: 29237721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis "Toxicol Appl Pharmacol. 2016;305:194-202".
    Lin CF; Huang HL; Peng CY; Lee YC; Wang HP; Teng CM; Pan SL
    Toxicol Appl Pharmacol; 2020 Jan; 387():114858. PubMed ID: 31843362
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].
    Liu YR; Sun B; Zhu GH; Li WW; Tian YX; Wang LM; Zong SM; Sheng PZ; Li M; Chen S; Qin Y; Liu HJ; Zhou HG; Sun T; Yang C
    Toxicol Appl Pharmacol; 2022 Jan; 435():115824. PubMed ID: 34890639
    [No Abstract]   [Full Text] [Related]  

  • 20. The clock gene Rev-erbα regulates pancreatic β-cell function: modulation by leptin and high-fat diet.
    Vieira E; Marroquí L; Batista TM; Caballero-Garrido E; Carneiro EM; Boschero AC; Nadal A; Quesada I
    Endocrinology; 2012 Feb; 153(2):592-601. PubMed ID: 22166979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.